Professor Giuseppe Saglio

Giuseppe Saglio, is Emeritus Professor of Hematology and Internal Medicine at the University of Turin (since 2020) and has been coordinator of the PhD program in Medicine and Experimental Therapy of the University of Turin and Director of the Department of Clinical and Biological Sciences of the same University.

He earned his medical degree and Ph.D. in hematology from the University of Turin, where he also completed his specialty training in internal medicine.

Giuseppe Saglio is known for his pioneering work on BCR-ABL mutations and molecular monitoring in CML and imatinib/nilotinib clinical studies. He retired from active clinical duties in 2023, but remains fully engaged in research, academic efforts, and organising international scientific meetings. 

Professor Saglio has published more than 600 peer-reviewed articles in the fields of molecular pathogenesis of haematological diseases, molecularly targeted therapy and molecular characterization of haematological malignancies. In 2017 he was nominated Knight of the Italian Republic for scientific merits and for his long lasting service for the Italian University and in 2021 he was awarded the iCMLf Goldman Prize.